U.S. markets open in 8 hours 38 minutes
  • S&P Futures

    3,951.25
    +6.25 (+0.16%)
     
  • Dow Futures

    33,681.00
    +48.00 (+0.14%)
     
  • Nasdaq Futures

    11,587.00
    +21.00 (+0.18%)
     
  • Russell 2000 Futures

    1,815.90
    +1.80 (+0.10%)
     
  • Crude Oil

    74.27
    +0.02 (+0.03%)
     
  • Gold

    1,784.90
    +2.50 (+0.14%)
     
  • Silver

    22.43
    +0.10 (+0.43%)
     
  • EUR/USD

    1.0468
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    3.5130
    -3.5130 (-100.00%)
     
  • Vix

    22.17
    -20.75 (-100.00%)
     
  • GBP/USD

    1.2127
    -0.0006 (-0.05%)
     
  • USD/JPY

    137.3280
    +0.3680 (+0.27%)
     
  • BTC-USD

    17,015.08
    +22.91 (+0.13%)
     
  • CMC Crypto 200

    401.56
    -0.25 (-0.06%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,721.90
    -163.97 (-0.59%)
     

G1 Therapeutics (GTHX)'s Technical Outlook is Bright After Key Golden Cross

From a technical perspective, G1 Therapeutics (GTHX) is looking like an interesting pick, as it just reached a key level of support. GTHX's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

A successful golden cross event has three stages. It first begins when a stock's price on the decline bottoms out. Then, its shorter moving average crosses above its longer moving average, triggering a positive trend reversal. The third and final phase occurs when the stock maintains its upward momentum.

A golden cross is the opposite of a death cross, another technical event that indicates bearish price movement may be on the horizon.

Over the past four weeks, GTHX has gained 72.7%. The company currently sits at a #3 (Hold) on the Zacks Rank, also indicating that the stock could be poised for a breakout.

The bullish case only gets stronger once investors take into account GTHX's positive earnings outlook for the current quarter. There have been 6 upwards revisions compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

Moving Average Chart for GTHX
Moving Average Chart for GTHX

Investors should think about putting GTHX on their watchlist given the ultra-important technical indicator and positive move in earnings estimates.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
G1 Therapeutics (GTHX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research